Sam Brusco, Associate Editor03.24.22
Teledermatology firm MedX Health has appointed Naman Demaghlatrous as its new president and CEO effective immediately. Demaghlatrous has over 20 years of healthcare and pharma industry experience.
He joined MedX in 2021 as managing director, Europe, Middle East, and Africa operations.
“Naman brings extensive knowledge of, and experience in, the global medical technology market,” Ken McKay, chairman of the MedX board of directors told the press. “His knowledge and experience in the European and North American marketplace will be a valuable asset in developing and expanding the Company’s growth plans in North America and internationally.”
“I would like to thank Ken and the Board of Directors for entrusting me with the responsibility of taking MedX to the next level,” said Demaghlatrous. “Globalizing MedX’s offering now that we have a proven methodology of pilot project to commercial contract is that next step. Penetrating new verticals, strengthening the team, while continuing to leverage our market access, training and education as well as our regulatory resources will both expand our footprint and accelerate our revenue growth.”
MedX’s telemedicine platform helps clinicians assess suspicious moles, lesions, and other skin conditions via SIAscopy image-capture technology and a secure, cloud-based patient management system.
He joined MedX in 2021 as managing director, Europe, Middle East, and Africa operations.
“Naman brings extensive knowledge of, and experience in, the global medical technology market,” Ken McKay, chairman of the MedX board of directors told the press. “His knowledge and experience in the European and North American marketplace will be a valuable asset in developing and expanding the Company’s growth plans in North America and internationally.”
“I would like to thank Ken and the Board of Directors for entrusting me with the responsibility of taking MedX to the next level,” said Demaghlatrous. “Globalizing MedX’s offering now that we have a proven methodology of pilot project to commercial contract is that next step. Penetrating new verticals, strengthening the team, while continuing to leverage our market access, training and education as well as our regulatory resources will both expand our footprint and accelerate our revenue growth.”
MedX’s telemedicine platform helps clinicians assess suspicious moles, lesions, and other skin conditions via SIAscopy image-capture technology and a secure, cloud-based patient management system.